Intrasense S.A. (EPA:ALINS)

Market Cap	11.37M -26.0%
Revenue (ttm)	2.65M +13.6%
Net Income	-6.48M
EPS	-0.12
Shares Out	52.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,203
Open	0.2160
Previous Close	0.2160
Day's Range	0.2010 - 0.2160
52-Week Range	0.1900 - 0.4300
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About Intrasense

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrase...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2004
• Employees: 76
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALINS

Financial Performance

In 2024, Intrasense's revenue was 2.25 million, a decrease of -32.04% compared to the previous year's 3.31 million. Losses were -5.66 million, 58.0% more than in 2023.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error